Bioniq, a London-based healthtech star, has reached a valuation of $82 million, significantly backed by Cristiano Ronaldo. The company’s innovative AI-driven supplements have attracted this high-profile investment.
Ronaldo’s involvement with Bioniq reflects not only financial backing but a partnership steeped in shared goals of health and performance excellence. Bioniq leverages cutting-edge technology to create personalised supplement solutions, setting a new standard in nutritional healthcare.
Cristiano Ronaldo’s Strategic Investment
Cristiano Ronaldo has made a significant investment in London-based healthtech company, Bioniq. The firm, specialising in AI-driven, personalised nutritional supplements, is now valued at $82 million. Ronaldo’s involvement follows a $15 million Series B funding round led by European venture capitalists HV Capital and Unbound. This move reflects Ronaldo’s commitment to promoting health and performance, both vital to his illustrious career.
Ronaldo brings his extensive experience as a world-class athlete to Bioniq, playing a direct role in product development. He utilises his personal insights into performance needs to enhance Bioniq’s offerings. His involvement is more than financial; it signals a shared vision for enhancing health and longevity through tailored nutritional solutions.
The Pioneers Behind Bioniq
Founded by Vadim Fedotov and Dr. Konstantin Karuzin in 2019, Bioniq operates at the intersection of healthtech and AI. The company customises supplements for individuals based on blood biomarker data, aiming to address nutrient deficiencies with precision. This is achieved through a patent-pending algorithm considering factors such as age, lifestyle, and health objectives.
Bioniq leverages AI to ensure each user’s unique health requirements are met. The algorithm analyses data to provide nutritional insights and support, including 1:1 consultations. This tech-forward approach has garnered support from renowned scientists, bolstering the company’s credibility. As of 2024, Bioniq operates in over 70 countries, witnessing a fivefold user base increase.
Revolutionising Supplement Delivery
Bioniq is transforming how supplements are manufactured and consumed.
All Bioniq products are Swiss-made and pharmaceutical-grade, ensuring high quality. The supplements employ micro-dosing strategies, individually tailoring formulas with up to 120 nutrients, including amino acids and phytonutrients. Unlike traditional capsules, Bioniq’s supplements utilise prebiotic guar granules. These granules enhance nutrient absorption by mimicking natural digestion, reducing nutrient competition in the body.
Partnerships with leading institutions like Lanserhof and the UFC reinforce Bioniq’s position in sports health. Bioniq’s approach, allowing nutrient need assessments pre and post-consumption, has made it a preferred choice among top-tier athletes globally.
Ronaldo’s alignment as both a shareholder and brand ambassador further underscores Bioniq’s commitment to excellence and innovation in personalised health.
A Dual Product Offering
Bioniq’s product range includes Bioniq Go and Bioniq Pro. Bioniq Go personalises supplements based on a brief quiz regarding individual needs, while Bioniq Pro offers an in-depth analysis through blood testing, allowing for more precise formulation.
These products utilise millions of biochemical data points to tailor solutions. By focusing on bioavailability, Bioniq ensures their ingredients are optimally absorbed. This dual offering allows Bioniq to cater to a wide range of users, addressing both casual health enthusiasts and those requiring more detailed health insights.
Ronaldo’s Endorsement and Vision
Cristiano Ronaldo’s participation in Bioniq’s growth is more than an investment; it is a partnership founded on a shared vision for future wellness. “Backing Bioniq goes beyond just an investment opportunity for me—it’s about aligning with a shared vision for health, performance, and longevity,” he noted.
Ronaldo’s commitment to Bioniq is multifaceted, involving direct contributions to brand and product innovation. His advocacy highlights the emerging importance of supplements in athletic performance and general wellness.
His belief in personalised health solutions is evident in his statement about using Bioniq products for years, indicating his confidence in their transformative potential.
Expanding Horizons
As Bioniq embarks on global expansion, it focuses on markets in the US, Europe, and the Middle East. The company aims to leverage Ronaldo’s international appeal to penetrate these markets effectively.
This expansion strategy aligns with Bioniq’s mission to empower millions globally with precise nutritional solutions. By addressing the evolving health needs of diverse populations, Bioniq sets a precedent for innovation in the healthtech sector.
Conclusion
Bioniq is set to revolutionise personalised health solutions with its AI-driven approach, bolstered by Ronaldo’s backing. The company is poised for significant growth, promising advancements in nutritional science and global healthcare innovation.
Bioniq’s partnership with Cristiano Ronaldo marks a critical stride in health innovation. Their work together promises to push the boundaries of personalised nutritional solutions, revolutionising how health and performance are approached.
